<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;ff=20240131011052&amp;utm_campaign=pubmed-2&amp;v=2.18.0&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;ff=20240131011052&amp;utm_campaign=pubmed-2&amp;v=2.18.0&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0)</generator>
<language>en</language>
<lastbuilddate>Wed, 31 Jan 2024 06:10:53 +0000</lastbuilddate>
<pubDate>Tue, 30 Jan 2024 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Ultra-processed foods and cardiovascular disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38291181/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Jan 30. doi: 10.1038/s41569-024-00990-7. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38291181/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38291181</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-00990-7>10.1038/s41569-024-00990-7</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38291181</guid>
<pubDate>Tue, 30 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Fernanda Rauber</dc:creator>
<dc:creator>Renata Bertazzi Levy</dc:creator>
<dc:date>2024-01-30</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Ultra-processed foods and cardiovascular disease</dc:title>
<dc:identifier>pmid:38291181</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-00990-7</dc:identifier>
</item>
<item>
<title>A 25-year odyssey of genomic technology advances and structural variant discovery</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38290514/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>This perspective focuses on advances in genome technology over the last 25 years and their impact on germline variant discovery within the field of human genetics. The field has witnessed tremendous technological advances from microarrays to short-read sequencing and now long-read sequencing. Each technology has provided genome-wide access to different classes of human genetic variation. We are now on the verge of comprehensive variant detection of all forms of variation for the first time with...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jan 23:S0092-8674(24)00004-7. doi: 10.1016/j.cell.2024.01.002. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">This perspective focuses on advances in genome technology over the last 25 years and their impact on germline variant discovery within the field of human genetics. The field has witnessed tremendous technological advances from microarrays to short-read sequencing and now long-read sequencing. Each technology has provided genome-wide access to different classes of human genetic variation. We are now on the verge of comprehensive variant detection of all forms of variation for the first time with a single assay. We predict that this transition will further transform our understanding of human health and biology and, more importantly, provide novel insights into the dynamic mutational processes shaping our genomes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38290514/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38290514</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.01.002>10.1016/j.cell.2024.01.002</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38290514</guid>
<pubDate>Tue, 30 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>David Porubsky</dc:creator>
<dc:creator>Evan E Eichler</dc:creator>
<dc:date>2024-01-30</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A 25-year odyssey of genomic technology advances and structural variant discovery</dc:title>
<dc:identifier>pmid:38290514</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.01.002</dc:identifier>
</item>
<item>
<title>Colchicine to prevent sympathetic denervation after acute myocardial infarction: the COLD-MI trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38289979/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jan 30:ehae042. doi: 10.1093/eurheartj/ehae042. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38289979/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38289979</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae042>10.1093/eurheartj/ehae042</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38289979</guid>
<pubDate>Tue, 30 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Fabien Huet</dc:creator>
<dc:creator>Denis Mariano-Goulart</dc:creator>
<dc:creator>Sylvain Aguilhon</dc:creator>
<dc:creator>Quentin Delbaere</dc:creator>
<dc:creator>Alain Lacampagne</dc:creator>
<dc:creator>Jérémy Fauconnier</dc:creator>
<dc:creator>Florence Leclercq</dc:creator>
<dc:creator>Jean-Christophe Macia</dc:creator>
<dc:creator>Mariama Akodad</dc:creator>
<dc:creator>Nidal Jammoul</dc:creator>
<dc:creator>Fabrice Prunier</dc:creator>
<dc:creator>Nathan Mewton</dc:creator>
<dc:creator>Denis Angoulvant</dc:creator>
<dc:creator>Catherine Lozza</dc:creator>
<dc:creator>Sonia Soltani</dc:creator>
<dc:creator>Annabelle Rodier</dc:creator>
<dc:creator>Sylvie Grandemange</dc:creator>
<dc:creator>Anne-Marie Dupuy</dc:creator>
<dc:creator>Jean-Paul Cristol</dc:creator>
<dc:creator>Mailis Amico</dc:creator>
<dc:creator>Nicolas Nagot</dc:creator>
<dc:creator>François Roubille</dc:creator>
<dc:date>2024-01-30</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Colchicine to prevent sympathetic denervation after acute myocardial infarction: the COLD-MI trial</dc:title>
<dc:identifier>pmid:38289979</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae042</dc:identifier>
</item>
<item>
<title>Utility of vector flow mapping and [18F]fluorodeoxyglucose-positron emission tomography/computed tomography to assess left ventricular workload in obstructive hypertrophic cardiomyopathy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38289896/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jan 30:ehae005. doi: 10.1093/eurheartj/ehae005. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38289896/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38289896</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae005>10.1093/eurheartj/ehae005</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38289896</guid>
<pubDate>Tue, 30 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Nobuhiro Tahara</dc:creator>
<dc:creator>Yoshihiro Fukumoto</dc:creator>
<dc:creator>Eiki Tayama</dc:creator>
<dc:date>2024-01-30</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Utility of vector flow mapping and [18F]fluorodeoxyglucose-positron emission tomography/computed tomography to assess left ventricular workload in obstructive hypertrophic cardiomyopathy</dc:title>
<dc:identifier>pmid:38289896</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae005</dc:identifier>
</item>
<item>
<title>Electrical storm treatment by percutaneous stellate ganglion block: the STAR study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38289867/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>CONCLUSIONS: The findings of this large, prospective, multicentre study provide evidence in favour of the effectiveness and safety of PSGB for the treatment of refractory ES.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jan 30:ehae021. doi: 10.1093/eurheartj/ehae021. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: An electrical storm (ES) is a clinical emergency with a paucity of established treatment options. Despite initial encouraging reports about the safety and effectiveness of percutaneous stellate ganglion block (PSGB), many questions remained unsettled and evidence from a prospective multicentre study was still lacking. For these purposes, the STAR study was designed.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This is a multicentre observational study enrolling patients suffering from an ES refractory to standard treatment from 1 July 2017 to 30 June 2023. The primary outcome was the reduction of treated arrhythmic events by at least 50% comparing the 12 h following PSGB with the 12 h before the procedure. STAR operators were specifically trained to both the anterior anatomical and the lateral ultrasound-guided approach.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 131 patients from 19 centres were enrolled and underwent 184 PSGBs. Patients were mainly male (83.2%) with a median age of 68 (63.8-69.2) years and a depressed left ventricular ejection fraction (25.0 ± 12.3%). The primary outcome was reached in 92% of patients, and the median reduction of arrhythmic episodes between 12 h before and after PSGB was 100% (interquartile range -100% to -92.3%). Arrhythmic episodes requiring treatment were significantly reduced comparing 12 h before the first PSGB with 12 h after the last procedure [six (3-15.8) vs. 0 (0-1), P &lt; .0001] and comparing 1 h before with 1 h after each procedure [2 (0-6) vs. 0 (0-0), P &lt; .001]. One major complication occurred (0.5%).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: The findings of this large, prospective, multicentre study provide evidence in favour of the effectiveness and safety of PSGB for the treatment of refractory ES.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38289867/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38289867</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae021>10.1093/eurheartj/ehae021</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38289867</guid>
<pubDate>Tue, 30 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Simone Savastano</dc:creator>
<dc:creator>Enrico Baldi</dc:creator>
<dc:creator>Sara Compagnoni</dc:creator>
<dc:creator>Roberto Rordorf</dc:creator>
<dc:creator>Antonio Sanzo</dc:creator>
<dc:creator>Francesca Romana Gentile</dc:creator>
<dc:creator>Veronica Dusi</dc:creator>
<dc:creator>Simone Frea</dc:creator>
<dc:creator>Carol Gravinese</dc:creator>
<dc:creator>Filippo Maria Cauti</dc:creator>
<dc:creator>Gianmarco Iannopollo</dc:creator>
<dc:creator>Francesco De Sensi</dc:creator>
<dc:creator>Edoardo Gandolfi</dc:creator>
<dc:creator>Laura Frigerio</dc:creator>
<dc:creator>Pasquale Crea</dc:creator>
<dc:creator>Domenico Zagari</dc:creator>
<dc:creator>Matteo Casula</dc:creator>
<dc:creator>Giuseppe Sangiorgi</dc:creator>
<dc:creator>Simone Persampieri</dc:creator>
<dc:creator>Gabriele Dell'Era</dc:creator>
<dc:creator>Giuseppe Patti</dc:creator>
<dc:creator>Claudia Colombo</dc:creator>
<dc:creator>Giacomo Mugnai</dc:creator>
<dc:creator>Francesco Notaristefano</dc:creator>
<dc:creator>Alberto Barengo</dc:creator>
<dc:creator>Roberta Falcetti</dc:creator>
<dc:creator>Giovanni Battista Perego</dc:creator>
<dc:creator>Giuseppe D'Angelo</dc:creator>
<dc:creator>Nikita Tanese</dc:creator>
<dc:creator>Alessia Currao</dc:creator>
<dc:creator>Vito Sgromo</dc:creator>
<dc:creator>Gaetano Maria De Ferrari</dc:creator>
<dc:creator>STAR study group</dc:creator>
<dc:date>2024-01-30</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Electrical storm treatment by percutaneous stellate ganglion block: the STAR study</dc:title>
<dc:identifier>pmid:38289867</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae021</dc:identifier>
</item>
<item>
<title>Plasma proteins can tell your biological organs' age (including the heart)</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38289864/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jan 30:ehae038. doi: 10.1093/eurheartj/ehae038. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38289864/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38289864</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae038>10.1093/eurheartj/ehae038</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38289864</guid>
<pubDate>Tue, 30 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Daniela Pedicino</dc:creator>
<dc:creator>Giovanna Liuzzo</dc:creator>
<dc:date>2024-01-30</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Plasma proteins can tell your biological organs' age (including the heart)</dc:title>
<dc:identifier>pmid:38289864</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae038</dc:identifier>
</item>
<item>
<title>On the importance of birth weight in relation to disease risk in later life</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38289862/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jan 30:ehad785. doi: 10.1093/eurheartj/ehad785. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38289862/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38289862</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad785>10.1093/eurheartj/ehad785</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38289862</guid>
<pubDate>Tue, 30 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Maryam Kavousi</dc:creator>
<dc:creator>Harold Snieder</dc:creator>
<dc:date>2024-01-30</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>On the importance of birth weight in relation to disease risk in later life</dc:title>
<dc:identifier>pmid:38289862</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad785</dc:identifier>
</item>
<item>
<title>To test or not to test for ischaemia routinely after percutaneous coronary intervention in diabetic patients: is the jury still out?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38289834/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jan 30:ehad877. doi: 10.1093/eurheartj/ehad877. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38289834/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38289834</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad877>10.1093/eurheartj/ehad877</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38289834</guid>
<pubDate>Tue, 30 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Roxy Senior</dc:creator>
<dc:creator>Rajdeep S Khattar</dc:creator>
<dc:date>2024-01-30</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>To test or not to test for ischaemia routinely after percutaneous coronary intervention in diabetic patients: is the jury still out?</dc:title>
<dc:identifier>pmid:38289834</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad877</dc:identifier>
</item>
<item>
<title>Transatlantic differences in the use of implantable cardioverter defibrillators in arrhythmogenic right ventricular cardiomyopathy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38289329/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jan 30:ehae022. doi: 10.1093/eurheartj/ehae022. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38289329/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38289329</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae022>10.1093/eurheartj/ehae022</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38289329</guid>
<pubDate>Tue, 30 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Perry Mark Elliott</dc:creator>
<dc:date>2024-01-30</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Transatlantic differences in the use of implantable cardioverter defibrillators in arrhythmogenic right ventricular cardiomyopathy</dc:title>
<dc:identifier>pmid:38289329</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae022</dc:identifier>
</item>
<item>
<title>The 2023 ESC guidelines for the management of cardiomyopathies: the 10 commandments</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38289320/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jan 30:ehad858. doi: 10.1093/eurheartj/ehad858. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38289320/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38289320</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad858>10.1093/eurheartj/ehad858</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38289320</guid>
<pubDate>Tue, 30 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Juan Pablo Kaski</dc:creator>
<dc:creator>Elena Arbelo</dc:creator>
<dc:date>2024-01-30</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The 2023 ESC guidelines for the management of cardiomyopathies: the 10 commandments</dc:title>
<dc:identifier>pmid:38289320</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad858</dc:identifier>
</item>
<item>
<title>A translational approach towards understanding brain waste clearance in cerebral amyloid angiopathy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38289319/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jan 30:ehae011. doi: 10.1093/eurheartj/ehae011. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38289319/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38289319</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae011>10.1093/eurheartj/ehae011</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38289319</guid>
<pubDate>Tue, 30 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Susanne J van Veluw</dc:creator>
<dc:creator>Helene Benveniste</dc:creator>
<dc:creator>Matthias J P van Osch</dc:creator>
<dc:creator>Leducq Foundation Transatlantic Network of Excellence on Brain Clearance</dc:creator>
<dc:date>2024-01-30</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>A translational approach towards understanding brain waste clearance in cerebral amyloid angiopathy</dc:title>
<dc:identifier>pmid:38289319</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae011</dc:identifier>
</item>
<item>
<title>Mitochondria and the heart</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38289316/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jan 30:ehae031. doi: 10.1093/eurheartj/ehae031. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38289316/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38289316</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae031>10.1093/eurheartj/ehae031</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38289316</guid>
<pubDate>Tue, 30 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Felippe Henrique Zuccolotto Dos Reis</dc:creator>
<dc:date>2024-01-30</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Mitochondria and the heart</dc:title>
<dc:identifier>pmid:38289316</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae031</dc:identifier>
</item>
<item>
<title>Deceased donor organ retrieval: impact on cardiovascular research</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38285900/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jan 29:ehae033. doi: 10.1093/eurheartj/ehae033. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38285900/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38285900</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae033>10.1093/eurheartj/ehae033</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38285900</guid>
<pubDate>Mon, 29 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Patrícia Afonso Mendes</dc:creator>
<dc:creator>Cristiane Pais Macedo</dc:creator>
<dc:creator>Sónia Moreira</dc:creator>
<dc:creator>Rogério Ferreira</dc:creator>
<dc:date>2024-01-29</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Deceased donor organ retrieval: impact on cardiovascular research</dc:title>
<dc:identifier>pmid:38285900</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae033</dc:identifier>
</item>
<item>
<title>Palpitations and Recurrent Syncope in a Young Woman</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38285741/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jan 30;149(5):402-405. doi: 10.1161/CIRCULATIONAHA.123.067865. Epub 2024 Jan 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38285741/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38285741</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067865>10.1161/CIRCULATIONAHA.123.067865</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38285741</guid>
<pubDate>Mon, 29 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Sun Yong Lee</dc:creator>
<dc:creator>Byron K Lee</dc:creator>
<dc:date>2024-01-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Palpitations and Recurrent Syncope in a Young Woman</dc:title>
<dc:identifier>pmid:38285741</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067865</dc:identifier>
</item>
<item>
<title>The Future of Pediatric and Adult Heart Transplantation: Perspective From the United States</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38285740/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jan 30;149(5):339-341. doi: 10.1161/CIRCULATIONAHA.123.065450. Epub 2024 Jan 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38285740/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38285740</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065450>10.1161/CIRCULATIONAHA.123.065450</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38285740</guid>
<pubDate>Mon, 29 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Emile Bacha</dc:creator>
<dc:creator>Maryjane Farr</dc:creator>
<dc:date>2024-01-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>The Future of Pediatric and Adult Heart Transplantation: Perspective From the United States</dc:title>
<dc:identifier>pmid:38285740</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065450</dc:identifier>
</item>
<item>
<title>LDL-C-Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia: Challenges and Successes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38285739/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jan 30;149(5):363-366. doi: 10.1161/CIRCULATIONAHA.123.067241. Epub 2024 Jan 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38285739/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38285739</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067241>10.1161/CIRCULATIONAHA.123.067241</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38285739</guid>
<pubDate>Mon, 29 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Raul D Santos</dc:creator>
<dc:creator>Marina Cuchel</dc:creator>
<dc:date>2024-01-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>LDL-C-Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia: Challenges and Successes</dc:title>
<dc:identifier>pmid:38285739</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067241</dc:identifier>
</item>
<item>
<title>Trajectories of Sleep Over Midlife and Incident Cardiovascular Disease Events in the Study of Women's Health Across the Nation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38284249/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>CONCLUSIONS: Insomnia symptoms, when persistent over midlife or occurring with short sleep, are associated with higher CVD risk among women.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jan 29. doi: 10.1161/CIRCULATIONAHA.123.066491. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Up to 50% of women report sleep problems in midlife, and cardiovascular disease (CVD) is the leading cause of death in women. How chronic poor sleep exposure over decades of midlife is related to CVD risk in women is poorly understood. We tested whether trajectories of insomnia symptoms or sleep duration over midlife were related to subsequent CVD events among SWAN (Study of Women's Health Across the Nation) participants, whose sleep was assessed up to 16 times over 22 years.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: At baseline, SWAN participants (n=2964) were 42 to 52 years of age, premenopausal or early perimenopausal, not using hormone therapy, and free of CVD. They completed up to 16 visits, including questionnaires assessing insomnia symptoms (trouble falling asleep, waking up several times a night, or waking earlier than planned ≥3 times/week classified as insomnia), typical daily sleep duration, vasomotor symptoms, and depressive symptoms; anthropometric measurements; phlebotomy; and CVD event ascertainment (ie, fatal or nonfatal myocardial infarction, stroke, heart failure, revascularization). Sleep trajectories (ie, insomnia, sleep duration) were determined by means of group-based trajectory modeling. Sleep trajectories were tested in relation to CVD in Cox proportional hazards models (multivariable models: site, age, race and ethnicity, education, CVD risk factors averaged over visits; additional covariates: vasomotor symptoms, snoring, depression).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Four trajectories of insomnia symptoms emerged: low insomnia symptoms (n=1142 [39% of women]), moderate insomnia symptoms decreasing over time (n=564 [19%]), low insomnia symptoms increasing over time (n=590 [20%]), and high insomnia symptoms that persisted (n=668 [23%]). Women with persistently high insomnia symptoms had higher CVD risk (hazard ratio, 1.71 [95% CI, 1.19, 2.46], <i>P</i>=0.004, versus low insomnia; multivariable). Three trajectories of sleep duration emerged: persistently short (~5 hours: n=363 [15%]), moderate (~6 hours: n=1394 [55%]), and moderate to long (~8 hours: n=760 [30%]). Women with persistent short sleep had marginally higher CVD risk (hazard ratio, 1.51 [95% CI, 0.98, 2.33], <i>P</i>=0.06, versus moderate; multivariable). Women who had both persistent high insomnia and short sleep had significantly elevated CVD risk (hazard ratio, 1.75 [95% CI, 1.03, 2.98], <i>P</i>=0.04, versus low insomnia and moderate or moderate to long sleep duration; multivariable). Relations of insomnia to CVD persisted when adjusting for vasomotor symptoms, snoring, or depression.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Insomnia symptoms, when persistent over midlife or occurring with short sleep, are associated with higher CVD risk among women.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38284249/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38284249</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.066491>10.1161/CIRCULATIONAHA.123.066491</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38284249</guid>
<pubDate>Mon, 29 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Rebecca C Thurston</dc:creator>
<dc:creator>Yuefang Chang</dc:creator>
<dc:creator>Christopher E Kline</dc:creator>
<dc:creator>Leslie M Swanson</dc:creator>
<dc:creator>Samar R El Khoudary</dc:creator>
<dc:creator>Elizabeth A Jackson</dc:creator>
<dc:creator>Carol A Derby</dc:creator>
<dc:date>2024-01-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Trajectories of Sleep Over Midlife and Incident Cardiovascular Disease Events in the Study of Women's Health Across the Nation</dc:title>
<dc:identifier>pmid:38284249</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.066491</dc:identifier>
</item>
<item>
<title>A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy Registry</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38282532/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>CONCLUSIONS: A model which accurately predicts LV recovery at 6 months in women with PPCM was derived. The corresponding ESC EORP PPCM Recovery Score can be easily applied in clinical practice to predict the probability of LV recovery for an individual in order to guide tailored counselling and treatment.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jan 29:ehad888. doi: 10.1093/eurheartj/ehad888. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: There are no established clinical tools to predict left ventricular (LV) recovery in women with peripartum cardiomyopathy (PPCM). Using data from women enrolled in the ESC EORP PPCM Registry, the aim was to derive a prognostic model to predict LV recovery at 6 months and develop the 'ESC EORP PPCM Recovery Score'-a tool for clinicians to estimate the probability of LV recovery.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: From 2012 to 2018, 752 women from 51 countries were enrolled. Eligibility included (i) a peripartum state, (ii) signs or symptoms of heart failure, (iii) LV ejection fraction (LVEF) ≤ 45%, and (iv) exclusion of alternative causes of heart failure. The model was derived using data from participants in the Registry and internally validated using bootstrap methods. The outcome was LV recovery (LVEF ≥50%) at six months. An integer score was created.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Overall, 465 women had a 6-month echocardiogram. LV recovery occurred in 216 (46.5%). The final model included baseline LVEF, baseline LV end diastolic diameter, human development index (a summary measure of a country's social and economic development), duration of symptoms, QRS duration and pre-eclampsia. The model was well-calibrated and had good discriminatory ability (C-statistic 0.79, 95% confidence interval [CI] 0.74-0.83). The model was internally validated (optimism-corrected C-statistic 0.78, 95% CI 0.73-0.82).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: A model which accurately predicts LV recovery at 6 months in women with PPCM was derived. The corresponding ESC EORP PPCM Recovery Score can be easily applied in clinical practice to predict the probability of LV recovery for an individual in order to guide tailored counselling and treatment.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38282532/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38282532</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad888>10.1093/eurheartj/ehad888</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38282532</guid>
<pubDate>Mon, 29 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Alice M Jackson</dc:creator>
<dc:creator>Sorel Goland</dc:creator>
<dc:creator>Hasan Ali Farhan</dc:creator>
<dc:creator>Israa Fadhil Yaseen</dc:creator>
<dc:creator>Hawani Sasmaya Prameswari</dc:creator>
<dc:creator>Michael Böhm</dc:creator>
<dc:creator>Pardeep S Jhund</dc:creator>
<dc:creator>Aldo P Maggioni</dc:creator>
<dc:creator>Peter van der Meer</dc:creator>
<dc:creator>Karen Sliwa</dc:creator>
<dc:creator>Johann Bauersachs</dc:creator>
<dc:creator>Mark C Petrie</dc:creator>
<dc:date>2024-01-29</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy Registry</dc:title>
<dc:identifier>pmid:38282532</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad888</dc:identifier>
</item>
<item>
<title>Gut-liver axis calibrates intestinal stem cell fitness</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38280375/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>The gut and liver are recognized to mutually communicate through the biliary tract, portal vein, and systemic circulation. However, it remains unclear how this gut-liver axis regulates intestinal physiology. Through hepatectomy and transcriptomic and proteomic profiling, we identified pigment epithelium-derived factor (PEDF), a liver-derived soluble Wnt inhibitor, which restrains intestinal stem cell (ISC) hyperproliferation to maintain gut homeostasis by suppressing the Wnt/β-catenin signaling...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jan 22:S0092-8674(24)00003-5. doi: 10.1016/j.cell.2024.01.001. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The gut and liver are recognized to mutually communicate through the biliary tract, portal vein, and systemic circulation. However, it remains unclear how this gut-liver axis regulates intestinal physiology. Through hepatectomy and transcriptomic and proteomic profiling, we identified pigment epithelium-derived factor (PEDF), a liver-derived soluble Wnt inhibitor, which restrains intestinal stem cell (ISC) hyperproliferation to maintain gut homeostasis by suppressing the Wnt/β-catenin signaling pathway. Furthermore, we found that microbial danger signals resulting from intestinal inflammation can be sensed by the liver, leading to the repression of PEDF production through peroxisome proliferator-activated receptor-α (PPARα). This repression liberates ISC proliferation to accelerate tissue repair in the gut. Additionally, treating mice with fenofibrate, a clinical PPARα agonist used for hypolipidemia, enhances colitis susceptibility due to PEDF activity. Therefore, we have identified a distinct role for PEDF in calibrating ISC expansion for intestinal homeostasis through reciprocal interactions between the gut and liver.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38280375/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38280375</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.01.001>10.1016/j.cell.2024.01.001</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38280375</guid>
<pubDate>Sat, 27 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Girak Kim</dc:creator>
<dc:creator>Zuojia Chen</dc:creator>
<dc:creator>Jian Li</dc:creator>
<dc:creator>Jialie Luo</dc:creator>
<dc:creator>Felipe Castro-Martinez</dc:creator>
<dc:creator>Jan Wisniewski</dc:creator>
<dc:creator>Kairong Cui</dc:creator>
<dc:creator>Yan Wang</dc:creator>
<dc:creator>Jialei Sun</dc:creator>
<dc:creator>Xiaobai Ren</dc:creator>
<dc:creator>Susan E Crawford</dc:creator>
<dc:creator>S Patricia Becerra</dc:creator>
<dc:creator>Jimin Zhu</dc:creator>
<dc:creator>Taotao Liu</dc:creator>
<dc:creator>Sui Wang</dc:creator>
<dc:creator>Keji Zhao</dc:creator>
<dc:creator>Chuan Wu</dc:creator>
<dc:date>2024-01-27</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Gut-liver axis calibrates intestinal stem cell fitness</dc:title>
<dc:identifier>pmid:38280375</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.01.001</dc:identifier>
</item>
<item>
<title>Gut complement induced by the microbiota combats pathogens and spares commensals</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38280374/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>Canonically, the complement system is known for its rapid response to remove microbes in the bloodstream. However, relatively little is known about a functioning complement system on intestinal mucosal surfaces. Herein, we report the local synthesis of complement component 3 (C3) in the gut, primarily by stromal cells. C3 is expressed upon commensal colonization and is regulated by the composition of the microbiota in healthy humans and mice, leading to an individual host's specific luminal C3...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jan 22:S0092-8674(24)00001-1. doi: 10.1016/j.cell.2023.12.036. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Canonically, the complement system is known for its rapid response to remove microbes in the bloodstream. However, relatively little is known about a functioning complement system on intestinal mucosal surfaces. Herein, we report the local synthesis of complement component 3 (C3) in the gut, primarily by stromal cells. C3 is expressed upon commensal colonization and is regulated by the composition of the microbiota in healthy humans and mice, leading to an individual host's specific luminal C3 levels. The absence of membrane attack complex (MAC) components in the gut ensures that C3 deposition does not result in the lysis of commensals. Pathogen infection triggers the immune system to recruit neutrophils to the infection site for pathogen clearance. Basal C3 levels directly correlate with protection against enteric infection. Our study reveals the gut complement system as an innate immune mechanism acting as a vigilant sentinel that combats pathogens and spares commensals.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38280374/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38280374</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.12.036>10.1016/j.cell.2023.12.036</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38280374</guid>
<pubDate>Sat, 27 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Meng Wu</dc:creator>
<dc:creator>Wen Zheng</dc:creator>
<dc:creator>Xinyang Song</dc:creator>
<dc:creator>Bin Bao</dc:creator>
<dc:creator>Yuanyou Wang</dc:creator>
<dc:creator>Deepshika Ramanan</dc:creator>
<dc:creator>Daping Yang</dc:creator>
<dc:creator>Rui Liu</dc:creator>
<dc:creator>John C Macbeth</dc:creator>
<dc:creator>Elyza A Do</dc:creator>
<dc:creator>Warrison A Andrade</dc:creator>
<dc:creator>Tiandi Yang</dc:creator>
<dc:creator>Hyoung-Soo Cho</dc:creator>
<dc:creator>Francesca S Gazzaniga</dc:creator>
<dc:creator>Marit Ilves</dc:creator>
<dc:creator>Daniela Coronado</dc:creator>
<dc:creator>Charlotte Thompson</dc:creator>
<dc:creator>Saiyu Hang</dc:creator>
<dc:creator>Isaac M Chiu</dc:creator>
<dc:creator>Jeffrey R Moffitt</dc:creator>
<dc:creator>Ansel Hsiao</dc:creator>
<dc:creator>John J Mekalanos</dc:creator>
<dc:creator>Christophe Benoist</dc:creator>
<dc:creator>Dennis L Kasper</dc:creator>
<dc:date>2024-01-27</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Gut complement induced by the microbiota combats pathogens and spares commensals</dc:title>
<dc:identifier>pmid:38280374</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.12.036</dc:identifier>
</item>
<item>
<title>Focus on vascular biology: new therapeutic targets in atherosclerosis, aortic dissection, and peripheral artery disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38279935/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240131011052&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jan 27;45(4):239-242. doi: 10.1093/eurheartj/ehae004.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38279935/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240131011052&v=2.18.0">38279935</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae004>10.1093/eurheartj/ehae004</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38279935</guid>
<pubDate>Sat, 27 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2024-01-27</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Focus on vascular biology: new therapeutic targets in atherosclerosis, aortic dissection, and peripheral artery disease</dc:title>
<dc:identifier>pmid:38279935</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae004</dc:identifier>
</item>





























</channel>
</rss>